<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        20-444-06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        EMIFEN 600 MG F-C TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        IBUPROFEN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        600
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLOBAL PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLOBAL PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 423]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            MANAYER NAJD TRADING MEDICAL NEEDS CO.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLOBAL PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Emifen belongs to a group of medicines called anti-inflammatory pain killers. Emifen can be used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis (including juvenile rheumatoid arthritis or Still&#39;s disease), arthritis of the spine, ankylosing spondylitis, swollen joints, frozen shoulder, bursitis, tendinitis, tenosynovitis, lower back pain, sprains and strains.</p><p>Emifen can also be used to treat other painful conditions such as toothache, pain after operations, period pain and headache, including migraine.</p><p>The active ingredient in Emifen is ibuprofen and each tablet contains 600 mg.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Are you pregnant or planning to become pregnant, or are you breast-feeding? Emifen may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant.</p><p>&bull; Are you sensitive (allergic) to any of the ingredients in Emifen? These are listed in Section 6.</p><p>&bull; Do you have, or have you previously had, a stomach ulcer or other gastric complaint?</p><p>Do not take Emifen if you currently have a peptic ulcer (ulcer in your stomach or duodenum) or bleeding in your stomach, or have had two or more episodes of peptic ulcers, stomach bleeding or perforation in the past.</p><p>&bull; Do you have a condition which increases your tendency to bleeding?</p><p>&bull; Do you suffer from asthma or have you ever had an allergic reaction or suffered from wheezing after taking ibuprofen, aspirin or other anti-inflammatory pain killers?</p><p>&bull; Do you suffer from swelling and irritation inside the nose?</p><p>&bull; Do you suffer from liver or kidney disease?</p><p>&bull; Do you suffer from heart disease?</p><p>&bull; Do you have an infection - please see heading &ldquo;Infections&rdquo; below.</p><p>Medicines such as Emifen may be associated with a small increased risk of heart attack (myocardial infarction) or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment.</p><p>You should discuss your treatment with your doctor or pharmacist before taking Emifen if you:</p><p>- have heart problems including heart failure, angina (chest pain) or you have had a heart attack, bypass surgery or peripheral artery disease (poor circulation in the legs or feet due to narrow or blocked arteries).</p><p>- have any kind of stroke or think that you might be at risk of these conditions (e.g. if you have a family history of heart disease or stroke, high blood pressure, diabetes, high cholesterol or are a smoker).</p><p>&bull; Do you have systemic lupus erythematosus (SLE, sometimes known as lupus) or a connective tissue disease (autoimmune diseases affecting connective tissue)?</p><p>&bull; Do you have chicken pox or shingles?</p><p>&bull; Are you or your child dehydrated? As there is a risk of kidney damage in dehydrated children adolescents and the elderly.</p><p><strong>Skin reactions</strong></p><p>Serious skin reactions have been reported in association with Emifen treatment. You should stop taking Emifen and seek medical attention immediately, if you develop any skin rash, lesions of the mucous membranes, blisters or other signs of allergy since this can be the first signs of a very serious skin reaction. See section 4.</p><p><strong>Infections</strong></p><p>Emifen may hide signs of infections such as fever and pain. It is therefore possible that Emifen may delay appropriate treatment of infection, which may lead to an increased risk of complications. This has been observed in pneumonia caused by bacteria and bacterial skin infections related to chickenpox. If you take this medicine while you have an infection and your symptoms of the infection persist or worsen, consult a doctor without delay.</p><p><strong>Can you take Emifen with other medicines?</strong></p><p>Some medicines that are anti-coagulants (i.e. thin blood/prevent clotting e.g. aspirin/acetylsalicyclic acid, warfarin, ticlodipine), some medicines that reduce high blood pressure (ACE-inhibitors such as captopril, beta-blockers such as atenolol, or angiotensin-II receptor antagonists such as losartan) and other medicines may affect or be affected by treatment with ibuprofen. You should therefore always seek the advice of your doctor or pharmacist before you use ibuprofen with other medicines. In particular you should tell your doctor or pharmacist if you are taking any of the following medicines in addition to those mentioned above:</p><p>&bull; diuretics (water)</p><p>&bull; cardiac glycosides, such as digoxin, used to treat heart conditions</p><p>&bull; lithium</p><p>&bull; zidovudine (an anti-viral drug)</p><p>&bull; steroids (used in the treatment of inflammatory conditions)</p><p>&bull; methotrexate (used to treat certain cancers and rheumatoid arthritis)</p><p>&bull; medicines known as immunosuppressants such as ciclosporin and tacrolimus (used to dampen down your immune response)</p><p>&bull; medicines known as selective serotonin reuptake inhibitors (SSRIs), used for the treatment of depression</p><p>&bull; antibiotics called quinolones such as ciprofloxacin</p><p>&bull; aminoglycosides (a type of antibiotic)</p><p>&bull; mifepristone</p><p>&bull; any other ibuprofen, such as those you can buy without a prescription</p><p>&bull; any other anti-inflammatory pain killer, including aspirin</p><p>&bull; cholestyramine (a drug used to lower cholesterol)</p><p>&bull; medicines known as sulphonylureas such as glibenclamide (used to treat diabetes)</p><p>&bull; voriconazole or fluconazole (type of anti-fungal drugs)</p><p>&bull; gingko biloba herbal medicine (there is a chance you may bleed more easily if you are taking this with ibuprofen).</p><p><strong>Alcohol:</strong> Emifen may cause some side effects including dizziness, drowsiness and stomach problems such as bleeding in the stomach. Drinking excessive alcohol while taking Emifen might make these side effects worse.</p><p><strong>Pregnancy and breast-feeding:</strong></p><p>The use of Emifen whilst pregnant or breast feeding should be avoided. Emifen should not be used in late (the last three months of) pregnancy and should only be taken in the first six months of pregnancy on the advice of your doctor.</p><p><strong>Driving and Using Machines:</strong></p><p>Emifen may make you feel dizzy or drowsy. If Emifen affects you in this way do not drive, operate machinery or do anything that requires you to be alert.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always </strong>take Emifen exactly as your doctor has told you. If you are not sure check with your doctor or pharmacist.</p><p>The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).</p><p>Take your Emifen with or after food, with a glass of water. Emifen should be swallowed whole and not chewed, broken, crushed or sucked to help prevent discomfort in the mouth or irritation in the throat.</p><p><strong>Dosage: </strong></p><p><strong>Adults and children over 12 years </strong>- The usual dosage is 600 to 1800 mg spread throughout the day. Your doctor may choose to increase this depending on what you are being treated for; but no more than 2400 mg should be taken in one day.</p><p><strong>Children </strong>&ndash; The usual daily dose is 20 mg per kg of bodyweight each day, given in divided doses. Emifen should <strong>NOT </strong>be taken by children weighing less than 7 kg.</p><p>Emifen 600 mg tablets should not be given to children under the age of 12 years.</p><p>In cases of severe juvenile arthritis your doctor my increase the dosage up to 40 mg/kg in divided doses.</p><p><strong>You should avoid excessive use of painkillers. </strong>If you usually take painkillers, especially combinations of different painkillers, you may damage your kidneys, <strong>tell your doctor if you are already taking another painkiller before taking this medicine and your doctor will decide whether you should take this medicine. </strong>This risk may be increased if you are dehydrated.</p><p>The use of painkillers for a long period of time has in some patients been linked to headaches, a condition called medication overuse headache (MOH). Patients who have frequent or daily headaches despite (or because of) the regular use of pain killers should not be treated with increased doses of Emifen. Tell your doctor if you have been having headaches while taking this medicine.</p><p><strong>If you take more Emifen than you should </strong></p><p>If you have taken more Emifen than you should, or if children have taken this medicine by accident always contact a doctor or nearest hospital to get an opinion of the risk and advice on action to be taken.</p><p>The symptoms can include nausea, stomach pain, vomiting (may be blood streaked), headache, ringing in the ears, confusion and shaky eye movement. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness and dizziness, blood in urine, cold body feeling, and breathing problems have been reported.</p><p><strong>If you forget to take Emifen</strong></p><p>Take Emifen as soon as you remember, unless it is almost time for your next dose. If it is, do not take the missed dose at all. Never double up on a dose to make up for the one you have missed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>As with all medicines, Emifen may cause side effects, although they are usually mild and not everyone will suffer from them. If any side effects become serious or if you notice any side effects that are not listed in this leaflet, please tell your doctor or pharmacist. You can minimise the risk of side effects by taking the least amount of Emifen for the shortest amount of time necessary to control your symptoms.</p><p><strong>STOP TAKING Emifen and seek immediate medical help if you experience: </strong></p><p>&bull; Signs of aseptic meningitis such as severe headache, high temperature, stiffness of the neck or intolerance to bright light.</p><p>&bull; Signs of intestinal bleeding such as</p><p>&bull; Passing blood in your faeces (stools/motions)</p><p>&bull; Passing black tarry stools</p><p>&bull; Vomiting any blood or dark particles that look like coffee grounds</p><p><strong>Tell your doctor and stop taking Emifen if you experience: </strong></p><p>&bull; Unexplained stomach pain (abdominal pain) or other abnormal stomach symptoms, indigestion, heartburn, feeling sick and/or vomiting.</p><p>&bull; Unexplained wheezing, shortness of breath, skin rash, itching or bruising (these may be symptoms of an allergic reaction).</p><p>&bull; Loss of vision, blurred or disturbed vision (visual impairment) or seeing/hearing strange things (hallucinations).</p><p>&bull; Severe spreading skin rash (&lsquo;Stevens-Johnson Syndrome&rsquo;, &lsquo;toxic epidermal necrolysis&rsquo; and &lsquo;erythema multiforme&rsquo;, symptoms include severe skin rash, blistering of skin, including inside mouth, nose, and genitals, as well as skin peeling which may be accompanied with symptoms such as aching, headaches, and feverishness)</p><p>&bull; A severe skin reaction known as DRESS syndrome can occur. Symptoms of DRESS include: skin rash, fever, swelling of lymph nodes and an increase of eosinophils (a type of white blood cells).</p><p>Medicines such as Emifen have been associated with a small increased risk of high blood pressure, heart attack (myocardial infarction), stroke or heart failure.</p><p>Medicines such as Emifen have in exceptional cases been associated with severe skin problems for patients with chicken pox or shingles</p><p>Blood disorders such as reduction in blood cells and platelet counts &ndash; the first signs are: high temperature, sore throat, mouth ulcers, flu-like symptoms, bleeding from the mouth, nose, ear and the skin. Kidney problems such as reduced kidney function, fluid retention (oedema), inflammation of the kidney and kidney failure. Liver problems such as inflammation of the liver, reduced liver function and yellowing of the eyes and/or skin (jaundice) or severe skin reactions may occur rarely with ibuprofen.</p><p>Emifen has also been shown to sometimes worsen the symptoms of Crohn&#39;s disease or colitis.</p><p><strong>Other side effects </strong></p><p><strong>Common (affects up to 1 in 10 people): </strong></p><p>&bull; feeling dizzy or tired</p><p>&bull; diarrhoea, wind, constipation</p><p>&bull; headache - if this happens while you are taking this medicine it is important not to take any other medicines for pain to help with this.</p><p><strong>Uncommon (affects up to 1 in a 100 people): </strong></p><p>&bull; feeling drowsy</p><p>&bull; feeling anxious</p><p>&bull; feeling a tingling sensation or &lsquo;pins and needles&rsquo;</p><p>&bull; difficulty sleeping</p><p>&bull; hives</p><p>&bull; skin becomes sensitive to light</p><p>&bull; hearing problems</p><p>&bull; sneezing, blocked, itchy or runny nose (rhinitis)</p><p>&bull; stomach or gut ulcer, hole in the wall of the digestive tract</p><p>&bull; inflammation of your stomach lining</p><p>&bull; ringing in ears (tinnitus)</p><p>&bull; sensation of spinning (vertigo)</p><p>&bull; mouth ulcers</p><p><strong>Rare (affects up to 1 in a 1000 people): </strong></p><p>&bull; feeling depressed or confused</p><p><strong>Very rare (affects up to 1 in 10,000 people): </strong></p><p>&bull; inflammation of the pancreas</p><p><strong>Not known (cannot be estimated from the available data):</strong></p><p>&bull; A red, scaly widespread rash with bumps under the skin and blisters mainly localized on the skin folds, trunk, and upper extremities accompanied by fever at the initiation of treatment (acute generalised exanthematous pustulosis). Stop using Emifen Suspension if you develop these symptoms and seek medical attention immediately. See also section 2.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep all medicines out of the sight and reach of children. Do not store above 30&deg;C.</p><p>Store in a dry place. Protect from light. Do not use Emifen after the expiry date which is stated after &lsquo;EXP&rsquo; on the blister and carton. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance in Emifen is ibuprofen BP.</p><p>Each film-coated tablet contains 600 mg of ibuprofen BP.</p><p>Tablet Excipients: Maize Starch, colloidal anhydrous silica , purified talc, sodium lauryl sulfate , stearic acid, pregelatinised starch, opadry white and isopropyl alcohol*</p><p>*Not present in the final formulation, evaporates upon drying</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Emifen 600 tablets are White to off-white film coated oval shaped tablets with GP7 embossed on one side and plain on other side.
Emifen 600 tablets are available in container packs of 20 tablets (10’s blister x 2).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Globalpharma Co. LLC, P. O. Box 72168, Dubai, UAE</p><p>Tel: +97148090900, Email: info@globalpharma.ae</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in November 2020 (RLD05/20)
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي إميفين إلى مجموعة من الأدوية تُسمى مسكنات الألم المضادة للالتهابات. يمكن استخدام إميفين&nbsp; لتخفيف الألم والالتهاب في الحالات المرضية مثل: التهاب المفاصل والتهاب المفاصل الروماتويدي (بما في ذلك، التهاب المفاصل الروماتويدي اليفعي (لدى المراهقين) أو مرض ستيل) والتهاب مفاصل العمود الفقري والتهاب الفقار اللاصق وتورم المفاصل وتجمد الكتف والتهاب الجراب والتهاب الأوتار والتهاب زليل الوتر وألم بالجزء السفلي من الظهر والالتواء والإجهاد.</p><p dir="RTL">كما يمكن استخدام إميفين لعلاج حالات مؤلمة أخرى مثل: ألم الأسنان وآلام ما بعد العمليات وآلام الدورة الشهرية والصداع بما في ذلك الصداع النصفي.</p><p dir="RTL">المادة الفعالة في إميفين هي إيبوبروفين ويحتوي كل قرص على ٦٠٠ ملجم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يُرجى إخبار </strong><strong>طبيبك أو الصيدلي الخاص بك إذا أجبت على أي من الأسئلة الآتية بـ&quot;نعم&quot; قبل تناول إميفين:</strong><strong> </strong></p><p dir="RTL">&bull; هل أنت حامل أو تعتزمين الحمل أو تمارسين الرضاعة الطبيعيَّة؟ قد يجعل إميفين حدوث الحمل أكثر صعوبة. يجب عليكِ إخبار طبيبك إذا كنتِ تخططين للحمل أو إذا كان لديكِ مشاكل في أن تصبحي حاملًا.</p><p dir="RTL">&bull; هل تعاني من حساسية تجاه أي من مكونات إميفين ؟ هذه المُكوِّنات مُدرَجة في قسم: ٦.</p><p dir="RTL">&bull; هل تعاني أو عانيت سابقًا من قرحة بالمعدة أو مشكلة أخرى بالمعدة؟</p><p dir="RTL">&bull; لا تتناول إميفين إذا كنت تعاني حاليًا من قُرحة هضمية (قرحة بالمعدة أو الإثنا عشر) أو نزيف في معدتك أو قد عانيت سابقًا من نوبتين أو أكثر من القرح الهضمية، نزيف أو انثقاب بالمعدة في الماضي.</p><p dir="RTL">&bull; هل أنت مُصاب بحالة مرضية تزيد من قابلية حدوث النزيف لديك؟</p><p dir="RTL">&bull; هل تعاني من الربو؟ أو هل أُصبت من قبل بتفاعل حساسية أو عانيت من أزيز بالصدر بعد تناول إيبوبروفين أو أسبرين أو غيرهما من مسكنات الألم المضادة للالتهاب؟</p><p dir="RTL">&bull; هل تعاني من تورم وتهيُّج بداخل الأنف؟</p><p dir="RTL">&bull; هل تعاني من أي مرض بالكبد أو الكلى؟</p><p dir="RTL">&bull; هل تعاني من أي مرض بالقلب؟</p><p dir="RTL">&bull; هل لديك عدوى - يرجى الاطلاع على العنوان &quot;العدوى&quot; أدناه.</p><p dir="RTL">&bull; قد ترتبط أدوية مثل إميفين بوجود زيادة ضئيلة في خطر الإصابة بالنوبة القلبية (احتشاء عضلة القلب) أو السكتة الدِّماغية. تَحدُث أي من هذه المخاطر بشكل أكبر مع الجرعات المرتفعة والعلاج المطول.</p><p dir="RTL">لا تتجاوز الجرعة أو فترة العلاج المُوصى بهما.</p><p dir="RTL">&nbsp;ينبغي عليك مناقشة علاجك مع طبيبك أو الصيدلي الخاص بك قبل تناوُل إميفين إذا كنت تعاني من الآتي:</p><p dir="RTL">- إذا كنت تعاني من مشاكل بالقلب بما في ذلك فشل القلب، الذبحة الصدرية (ألم بالصدر) أو قد أُصِبت بنوبة قلبية، أو خضعت لجراحة مَجازَة، أو قد أصبت بمرض الشرايين الطرفية (ضعف الدورة الدَّموية في الساقين أو القدمين نتيجة تضيُّق أو انسداد الشرايين).</p><p dir="RTL">- إذا كنت تعاني من سكتة دماغية أيًّا كان نوعها أو كنت تظن أنك قد تكون عرضة لخطر الإصابة بهذه الحالات (على سبيل المثال: إذا كان لديك تاريخ مرضي عائلي من الإصابة بمرض قلبي أو سكتة دماغية أو ارتفاع ضغط الدَّم أو مرض السُّكَّرِي أو ارتفاع الكوليسترول أو إذا كنت تدخن).</p><p dir="RTL">&bull; هل تعاني من ذئبة حمامية جهازية (تُعرف أحيانًا بالذئبة) أو أي مرض بالأنسجة الضامة (أمراض مناعية ذاتية تصيب الأنسجة الضامة)؟</p><p dir="RTL">&bull; هل أنت مُصاب بالحُماق أو الهربس النطاقي؟</p><p dir="RTL">&bull; هل تعاني أو يعاني طفلك من الجفاف؟ إذ إن هناك خطر لحدوث تلف بالكلى لدى الأطفال والمراهقين وكبار السن الذين يعانون من الجفاف.</p><p dir="RTL"><strong>التفاعلات الجلدية</strong><strong>.</strong></p><p dir="RTL">جرى الإبلاغ عن حدوث تفاعلات جلدية خطيرة بمصاحبة العلاج بعقار إميفين. عليك التوقف عن تناوُل إميفين وطلب العناية الطبية فورًا، إذا أُصِبت بأي حالة من حالات الطفح الجلدي أو إصابات بالأغشية المخاطية أو بثور أو غيرها من علامات الحساسية؛ إذ قد تكون هذه العلامات الأولى لحدوث إحدى التفاعلات الجلدية شديد الخطورة.</p><p dir="RTL">انظر قسم: ٤.</p><p dir="RTL"><strong>العدوى</strong></p><p dir="RTL">قد يخفي إميفين علامات العدوى مثل الحمى والألم. لذلك من الممكن أن يؤخر إميفين العلاج المناسب للعدوى ، مما قد يؤدي إلى زيادة خطر حدوث مضاعفات. وقد لوحظ هذا في الالتهاب الرئوي الناجم عن البكتيريا والتهابات الجلد البكتيرية المتعلقة بجدري الماء. إذا كنت تتناول هذا الدواء أثناء إصابتك بعدوى واستمرت أعراض العدوى أو تفاقمت، فاستشر الطبيب دون تأخير.</p><p dir="RTL"><strong>هل يمكنك تناول&nbsp; إميفين&nbsp; بمصاحبة أدوية أخرى؟ </strong></p><p dir="RTL">قد تُؤثر بعض الأدوية المضادة للتخثر (أي المسيلة للدَّم/ التي تمنع التخثر على سبيل المثال: الأسبرين/ حمض أستيل الساليسيليك، وارفارين، تيكلوديبين) وبعض الأدوية التي تحد من ارتفاع ضغط الدَّم (مثبطات الإنْزيم المُحَوِّل للأَنْجيُوتَنْسينِ مثل: كابْتُوبْرِيل، حاصرات بيتا مثل: أتينولول أو مناهضات مستقبلات الأنجيوتنسين- 2 مثل: لوسارتان) وغيرها من الأدوية، على العلاج بإيبوبروفين أو قد تتأثر به. ولذلك ينبغي عليك استشارة طبيبك أو الصيدلي الخاص بك دائمًا قبل استخدام إيبوبروفين بمصاحبة أدوية أخرى. وعلى وجه الخصوص، يجب عليك إخبار طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أيًّا من الأدوية التَّالية بالإضافة إلى تلك الأدوية المذكورة أعلاه:</p><p dir="RTL">&bull; مدرات البول ( الماء).</p><p dir="RTL">&bull; جليكوزيدات القلب التي تُستخدَم لعلاج حالات القلب مثل ديجوكسِين.</p><p dir="RTL">&bull; الليثيوم.</p><p dir="RTL">&bull; زيدوفودين ( مضاد للفيروسات).</p><p dir="RTL">&bull; الستيرويدات (تُستَخدَم في علاج حالات الالتهاب).</p><p dir="RTL">&bull; ميثوتريكسات (يُستخدم لعلاج بعض أنواع السرطان والتهاب المفاصل الروماتويدي).</p><p dir="RTL">&bull;الأدوية التي تُعرف بمثبطات المناعة مثل: سيكلوسبورين وتاكروليموس (تُستخدم لكبح استجابتك المناعية).</p><p dir="RTL">&bull; الأدوية التي تُعرف بمثبطات إعادة امتصاص السيروتونين الانتقائية، تُستخدَم لعلاج الاكتئاب.</p><p dir="RTL">&bull; المضادات الحيوية التي تُدعى الكينولونات مثل سيبروفلوكساسين.</p><p dir="RTL">&bull; الأمينُوجْليكُوزيدات (أحد أنواع المضادت الحيوية).</p><p dir="RTL">&bull; ميفيبريستون.</p><p dir="RTL">&bull; أي أدوية أخرى تحتوي على إيبوبروفين مثل تلك التي يمكنك شراؤها دون وصفة طبية.</p><p dir="RTL">&bull; أي مسكنات ألم أخرى مضادة للالتهاب، بما في ذلك الأسبرين.</p><p dir="RTL">&bull; كولستيرامين (دواء يُستَخدَم لخفض الكوليسترول).</p><p dir="RTL">&bull; الأدوية التي تُعرف بسلفونيل يوريا مثل جليبنكلاميد (تُستَخدَم لعلاج مرض السُّكَّرِي).</p><p dir="RTL">&bull; فوريكونازول أو فلوكونازول (نوع من أنواع العقاقير المضادة للفطريات).</p><p dir="RTL">&bull; دواء جينكو ثنائي الفلقة &quot;جينكو بيلوبا&quot; العشبي (هناك احتمالية أن تصاب بنزيف بسهولة أكبر إذا كنت تتناوله بمصاحبة إيبوبروفين).</p><p dir="RTL"><strong>الكحوليات:</strong> قد يُسبب إميفين حدوث بعض التأثيرات الجانبية وتشمل الدوخة والنُعاس ومشاكل المعدة مثل نزيف المعدة. شرب الكحوليات بإفراط أثناء تناوُل إميفين قد يؤدي إلى تفاقم هذه التأثيرات الجانبية المحتملة.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية </strong>ينبغي تجنُّب استخدام إميفين أثناء الحمل أو ممارسة الرضاعة الطبيعية. ينبغي عدم استخدام إميفين في أواخر الحمل (الثلاثة أشهر الأخيرة من الحمل) وينبغي ألَّا يتم تناوله إِلَّا خلال الستة أشهر الأولى من الحمل بناءً على نصيحة طبيبكِ.</p><p dir="RTL"><strong>ممارسة القيادة واستخدام الآلات:</strong> قد يجعلك إميفين تشعر بدوخة أو نعاس. إذا كان إميفين يؤثر عليك بهذا الشكل فلا تمارس القيادة أو تشغل الآلات أو تقم بأي شيء يتطلب أن تكون يقظًا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول <strong>دائمًا</strong> إميفين كما أخبرك طبيبك بالضبط. يُرجى مراجعة طبيبك أو الصيدلي الخاص بك ، إذا لم تكن متأكدًا من كيفية التناول.</p><p dir="RTL">يجب استخدام أقل جرعة فعالة لأقصر مدة ضرورية لتخفيف الأعراض. إذا كنت مصابًا بعدوى ، فاستشر الطبيب دون تأخير إذا استمرت الأعراض (مثل الحمى والألم) أو ساءت (انظر القسم ٢).</p><p dir="RTL">تناول إميفين مع الطعام أو بعد الانتهاء منه مع كوب من الماء. ينبغي ابتلاع أقراص إميفين كاملة وينبغي عدم مضغها أو كسرها أو سحقها أو امتصاصها؛ كي لا تسبب ضيقًا بالفم أو تهيُّجًا بالحلق.</p><p dir="RTL"><strong>الجُرعة: </strong></p><p dir="RTL"><strong>البالغون والأطفال ممن تجاوزوا ١٢ عامًا - </strong>تتراوح الجرعة المعتادة بين ٦٠٠ و ١٨٠٠ ملجم ويتم تقسيمها على مدار اليوم. قد يقرر طبيبك زيادة هذه الجرعة بناءً على ما تُعالج منه إِلَّا أنه ينبغي عدم تناول أكثر من ٢٤٠٠ ملجم في يوم واحد.</p><p dir="RTL"><strong>الأطفال - </strong>تبلغ الجرعة اليومية المعتادة ٢٠ ملجم لكل كجم من وزن الجسم كل يوم، يتم إعطاؤها على هيئة جرعات مُقَسَّمة. ينبغي <strong>عدم</strong> تناول إميفين من قبل الأطفال ممن تقل أوزانهم عن ٧ كجم.</p><p dir="RTL">لا يجب إعطاء أقراص إميفين التي تحتوي على ٦٠٠&nbsp; ملجم للأطفال ممن تقل أعمارهم عن ١٢ عامًا.</p><p dir="RTL">في حال الإصابة بالتهاب المفاصل الروماتويدي اليفعي الشديد، قد يزيد طبيبك الجرعة ؛ لتصل إلى ٤٠ ملجم/ كجم وسيتم إعطاؤها على هيئة جرعات مُقَسَّمة.</p><p dir="RTL">&nbsp;<strong>ينبغي عليك تجنب الاستخدام المفرط لمسكنات الألم. </strong>إذا كنت تتناول مسكنات الألم عادة، خاصةً إذا كنت تتناول مزيجًا من مسكنات ألم مختلفة، فقد تتسبب في إتلاف الكُلى لديك، <strong>أخبر طبيبك إذا كنت تتناول بالفعل مسكن ألم آخر قبل تناول هذا الدَّواء وسيقرر طبيبك ما إذا كان ينبغي عليك تناول هذا الدَّواء أم لا. </strong>قد يزداد هذا الخطر إذا كنت مُصابًا بالجفاف.</p><p dir="RTL">ارتبط استخدام مسكنات الألم لفترة زمنية طويلة لدى بعض المرضى بحدوث صداع، وهي حالة تُسمى الصداع الناجم عن الاستخدام الزائد للدَّواء. يجب على المرضى الذين يُعانون من حالات متكررة أو يومية من الصداع على الرغم من (أو بسبب) الاستخدام المستمر لمسكنات الألم عدم تلقي العلاج بجرعات مرتفعة من عقار إيميفين. أخبر طبيبك إذا كنت تعاني من حالات صداع أثناء تناوُل هذا الدَّواء</p><p dir="RTL"><strong>إذا تناولت إميفين أكثر مما يجب </strong></p><p dir="RTL">إذا تناولت كمية أكثر مما ينبغي من&nbsp; إميفين أو إذا تناول الأطفال هذا الدَّواء بطريق الخطأ، فاتصل بالطبيب أو بأقرب مستشفى؛ للحصول على رأي حول المخاطر وكذلك الحصول على نصيحة حول الإجراء الذي ينبغي اتخاذه.</p><p dir="RTL">قد تشمل الأعراض: الغثيان وألمًا بالمعدة وقيئًا (قد يكون مصحوبًا بدم) وصداعًا وطنينًا بالأذن وارتباكًا/ التباسًا وعدم ثبات حركة العين. عند تناول جرعات مرتفعة، تم الإبلاغ عن التَّعرض لنعاس وألم بالصدر وخَفَقان وفقدان الوعي وتشنجات (لدى الأطفال بشكل أساسي) وضعف ودوخة وبول مصحوب بدم وشعور ببرودة الجسم ومشاكل بالتنفس.</p><p dir="RTL"><strong>إذا أغفلت تناول إميفين </strong></p><p dir="RTL">تناول إميفين بمجرد أن تتذكر، ما لم يكن ذلك الوقت هو تقريبًا وقت تناول الجرعة التَّالية. إذا حان وقت الجرعة التَّالية بالفعل، فلا تتناول الجرعة التي أغفلتها على الإطلاق. إياك ومضاعفة الجرعة لتعويض الجرعة التي أغفلتها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع كافة الأدوية، قد يسبب إميفين آثارًا جانبية ، إِلَّا أنها عادة ما تكون بسيطة ولن يعاني منها الجميع. إذا أصبح أيٌّ من الآثار الجانبية خطيرًا، أو إذا لاحظت أية آثار جانبية غير واردة في هذه النَّشرة، يُرجى إبلاغ طبيبك أو الصيدلي الخاص بك. يمكنك الحد من خطر الإصابة بالآثار الجانبية من خلال تناول أقل كمية من إميفين لأقصر مدة لازمة للتحكم بأعراضك.</p><p dir="RTL"><strong>توقف عن تناول إميفين واطلب المساعدة الطبية الفورية إذا تعرضت للآتي: </strong></p><p dir="RTL">&bull; علامات تُشير إلى الإصابة بالتهاب السحايا غير الصديدي مثل الصداع الشديد أو ارتفاع درجة الحرارة أو تصلب الرقبة أو عدم تحمل الضوء الساطع.</p><p dir="RTL">&bull; علامات تُشير إلى حدوث نزيف بالأمعاء مثل الآتي:</p><p dir="RTL">&bull; وجود دم بالبراز الخاص بك.</p><p dir="RTL">&bull; إخراج براز أسود قطراني اللون.</p><p dir="RTL">&bull; قيء مصحوب بدم أو جزئيات داكنة اللون شبيهة بالبن المطحون.</p><p dir="RTL"><strong>أخبر طبيبك وتوقف عن تناول إميفين إذا عانيت من الآتي: </strong></p><p dir="RTL">&bull; ألم غير مبرر بالمعدة (ألم بالبطن) أو أعراض أخرى غير طبيعية بالمعدة، عسر الهضم، حموضة، شعور بالإعياء و/ أو قيء.</p><p dir="RTL">&bull; أزيز غير مبرر بالصدر، ضيق التَّنفس، طفح جلدي، حكة أو كدمات (قد تكون هذه الأعراض خاصة بأحد تفاعلات الحساسية).</p><p dir="RTL">&bull; فقدان الرؤية، عدم وضوح الرؤية أو اضطرابها (قصور البصر) أو رؤية/ سماع أشياء غريبة (هلاوس).</p><p dir="RTL">&bull; طفح جلدي شديد الانتشار (&quot;متلازمة ستيفنز جونسون&quot;، &quot;انحلال البشرة النخري التَّسَمُّمِيّ&quot; و&quot;الاحمرار متعدد الأشكال&quot;، تشمل الأعراض: طفحًا جلديًّا شديدًا، ظهور بثور بالجلد، بما في ذلك داخل الفم والأنف والأعضاء التَّناسلية، بالإضافة إلى تقشر الجلد الذي قد يكون مصحوبًا بأعراض مثل: ألم وصداع وارتفاع درجة حرارة الجسم).</p><p dir="RTL">&bull; قد يحدث تفاعل جلدي شديد يُعرف بمتلازمة الطفح الجلدي الدَّوائي المصحوب بكثرة خلايا اليُوزينِيَّات والأعراض الجهازية. تشمل أعراض الطفح الجلدي الدَّوائي المصحوب بكثرة خلايا اليُوزينِيَّات والأعراض الجهازية طفحًا جلديًّا وحمى وتورم العقد الليمفاوية وزيادة الحمضات (أحد أنواع خلايا الدَّم البيضاء).</p><p dir="RTL">اقترن استخدام الأدوية مثل إميفين بحدوث زيادة ضئيلة في خطر الإصابة بارتفاع ضغط الدَّم أو النوبة القلبية (احتشاء عضلة القلب) أو السكتة الدِّماغية أو فشل القلب.</p><p dir="RTL">اقترن استخدام الأدوية مثل إميفين في حالات استثنائية بحدوث مشاكل جلدية شديدة لدى المرضى المصابين بالحُماق أو الهربس النطاقي.</p><p dir="RTL">قد تحدث اضطرابات بالدَّم مثل: انخفاض في تعداد خلايا الدَّم وتعداد الصفائح الدَّموية - تشمل العلامات الأولى ارتفاع درجة الحرارة، التهاب الحلق، تقرح الفم، أعراض شبيهة بأعراض الأنفلونزا، نزيف من الفم والأنف والأذن والجلد. وقد تحدث مشاكل بالكُلى مثل قصور بوظائف الكُلى واحتباس السوائل (وذمة) والتهاب الكُلى والفشل الكلوي. نادرًا ما قد تحدث مشاكل بالكبد مثل التهاب الكبد وقصور بوظائف الكبد واصفرار العينين و/ أو الجلد (يرقان) أو تفاعلات جلدية شديدة بمصاحبة إيبوبروفين.</p><p dir="RTL">تبين أيضًا أن إميفين يسبب أحيانًا تفاقم أعراض مرض كرون أو التهاب القولون.</p><p dir="RTL"><strong>الآثار الجانبية الأخرى </strong></p><p dir="RTL"><strong>شائعة (تُؤثر على ما يصل إلى شخص واحد من بين كل ١٠&nbsp;أشخاص): </strong></p><p dir="RTL">&bull; شعور بدوخة أو تعب.</p><p dir="RTL">&bull; إِسْهال، ريح، إمساك.</p><p dir="RTL">&bull; صداع - إذا أُصبت به أثناء تناولك لهذا الدَّواء فمن المهم عدم تناول أي أدوية أخرى لعلاج الألم؛ للمساعدة على تخفيفه.</p><p dir="RTL"><strong>غير شائعة (تُؤثر على ما يصل إلى شخص واحد من بين كل ١٠٠ شخص): </strong></p><p dir="RTL">&bull; شعور بالنُّعاس.</p><p dir="RTL">&bull; شعور بالقلق.</p><p dir="RTL">&bull; شعور بتنميل أو &quot;وخز شبيه بالإبر والمسامير&quot;.</p><p dir="RTL">&bull; صعوبة بالنوم.</p><p dir="RTL">&bull; شرى (أرتكاريا).</p><p dir="RTL">&bull; حساسية الجلد تجاه الضوء.</p><p dir="RTL">&bull; مشاكل في السمع.</p><p dir="RTL">&bull; العطس، انسداد الأنف أو حكة به أو سيلانه (التهاب الأنف).</p><p dir="RTL">&bull; قرح بالأمعاء أو المعدة، ثقب في جدار الجهاز الهضمي.</p><p dir="RTL">&bull; التهاب بطانة المعدة لديك.</p><p dir="RTL">&bull; طنين بالأذنين.</p><p dir="RTL">&bull; شعور بالدوران (دوار).</p><p dir="RTL">&bull; قُرَح بالفم.</p><p dir="RTL"><strong>نادرة (تُؤثر على ما يصل إلى شخص واحد من بين كل ١٠٠٠ شخص): </strong></p><p dir="RTL">&bull; شعور بالاكتئاب أو الارتباك.</p><p dir="RTL"><strong>نادرة جدًّا (تُؤثر على ما يصل إلى شخص واحد من بين كل ١٠٠٠٠ شخص): </strong></p><p dir="RTL">&bull; التهاب البنكرياس.</p><p><strong>غير معروفة (لا يمكن تقديرها من واقع البيانات المتاحة):</strong></p><p>&nbsp; طفح جلدي أحمر اللون متقشر واسع الانتشار مع وجود كتل أسفل الجلد وبثور توجد بثنيات الجلد والجذع والأطراف العلوية بشكلٍ أساسي مصحوبة بحُمّى عند بدء العلاج (البُثَار الطَّفَحِيّ الحَاد المُعَمَّم). توقف عن استخدام إميفين إذا أُصِبت بهذه الأعراض واطلب العناية الطبية فورًا انظر أيضًا قسم: ٢.</p><p>إذا أصبح أي عرض من الأعراض الجانبية خطيرًا أو إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، فضلا أخبر طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تحفظ الأدوية بعيدا عن رؤية ومتناول الأطفال. &nbsp;يحفظ في درجة حرارة لا تزيد عن ۳۰ درجة مئوية في مكان جاف بعيدا عن الضوء. لا تستخدم إميفين بعد انتهاء تاريخ الصلاحية المدون على الشريط والعبوة بعد كلمة &laquo;EXP&raquo; . يجب عدم التخلص من الأدوية عن طريق إلقائها في مياه الصرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد تلك الإجراءات في حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة في إميفين هي: إيبوبروفين (طبقا لدستور الأدوية البريطاني).</p><p dir="RTL">&nbsp;يحتوي كل قرص مغلف على ايبوبروفين ٦٠٠ ملجم (طبقا لدستور الأدوية البريطاني) .</p><p dir="RTL">أقراص إميفين ٦٠٠ ملجم تتوفر في عبوات تحتوي على ٢٠ قرص ( شريطان بكل منهما ١٠ أقراص).</p><p dir="RTL">&nbsp;سواغات القرص هي:</p><p dir="RTL">نشا الذرة ، سيليكا لامائية غروية ، بودرة التلك المنقى ، كبريتات لوريل الصوديوم ، حامض الستيريك ، نشا معدّل ، أوبادري أبيض وكحول الآيزوبروبيل*</p><p dir="RTL">*غير موجود في التركيبة النهائية ، يتبخر عند التجفيف</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص إميفين ٦٠٠ ملجم هي أقراص مغلفة بيضاوية الشكل يميل لونها بين الأبيض والأبيض المائل للصفرة، محفور على أحد جانبيها <strong>GP7</strong> والجانب الآخر خال من الحفر .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة جلوبال فارما ذ.م.م.، ص.ب. ۷۲۱٦٨ ، دبي ، الامارات العربية المتحدة .</p><p dir="RTL">هاتف: /٩٧١٤٨٠٩٠٩٠٠+/&nbsp; ، بريد إلكتروني: info@globalpharma.ae</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم آخر تحديث لهذه النشرة في نوفمبر ٢٠٢٠ (RLD05/20)
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Emifen 600 mg Film-Coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains 600 mg Ibuprofen BP

For the full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                White to off-white film coated oval shaped tablets with GP7 embossed on one side and plain on other side  
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Emifen is indicated for its analgesic and anti-inflammatory effects in the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or Still&#39;s disease), ankylosing spondylitis, osteoarthritis and other non-rheumatoid (seronegative) arthropathies.</p><p>In the treatment of non-articular rheumatic conditions, Emifen is indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendinitis, tenosynovitis and low back pain; Emifen can also be used in soft tissue injuries such as sprains and strains.</p><p>Emifen is also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain and for symptomatic relief of headache, including migraine headache</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p>Adults and children over 12 years of age : The recommended dosage of Emifen is 1200-1800 mg daily in divided doses. Some patients can be maintained on 600-1200 mg daily. In severe or acute conditions, it can be advantageous to increase the dosage until the acute phase is brought under control, provided that the total daily dose does not exceed 2400 mg in divided doses.</p><p>In Juvenile Rheumatoid Arthritis, up to 40 mg/kg of body weight daily in divided doses may be taken.</p><p>Tablets are not suitable for children under the age of 12 years.</p><p>Elderly: The elderly are at increased risk of serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy. If renal or hepatic function is impaired, dosage should be assessed individually.</p><p>Renal impairment:</p><p>Patients with mild to moderate renal impairment, (see section 4.4 - Special warnings and precautions for use) and patients with severe renal insufficiency (see section 4.3 &ndash; Contraindications)</p><p>Hepatic impairment:</p><p>For patients with mild to moderate hepatic impairment (see section 4.4 Special warnings and precautions for use) and patients with severe hepatic dysfunction (see section 4.3-Contraindications).</p><p>For oral administration. It is recommended that patients with sensitive stomachs take Emifen with food. If taken shortly after eating, the onset of action of Emifen may be delayed.<strong>&nbsp;</strong>To be taken preferably with or after food, with plenty of fluid. Emifen tablets should be swallowed whole and not chewed, broken, crushed or sucked on to avoid oral discomfort and throat irritation.</p><p>The lowest effective dose should be used for the shortest duration necessary to relieve symptoms (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Emifen is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients.
Emifen should not be used in patients who have previously shown hypersensitivity reactions (e.g. asthma, urticaria, angioedema or rhinitis) after taking ibuprofen, aspirin or other NSAIDs.
Emifen is also contraindicated in patients with a history of gastrointestinal bleeding or perforation, related to previous NSAID therapy. Emifen should not be used in patients with active, or history of, recurrent peptic ulcer or gastrointestinal haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
Emifen should not be given to patients with conditions involving an increased tendency to bleeding.
Emifen is contraindicated in patients with severe heart failure (NYHA Class IV), hepatic failure and renal failure (see section 4.4).
Emifen is contraindicated during the last trimester of pregnancy (see section 4.6).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks below).</p><p>As with other NSAIDs, ibuprofen may mask the signs of infection.</p><p>The use of Emifen with concomitant NSAIDs, including cyclooxygenase-2 selective inhibitors, should be avoided due to the increased risk of ulceration or bleeding (see section 4.5).</p><p>The diagnosis of medication overuse headache (MOH) should be suspected in patients who have frequent or daily headaches despite (or because of) the regular use of analgesic medication. Patients with medication overuse headache should not be treated by increasing the dose of the analgesic. In such cases the use of analgesics should be discontinued.</p><p>The concomitant consumption of excessive alcohol with NSAIDs, including ibuprofen may increase the risk of adverse effects on the gastrointestinal tract, such as GI haemorrhage or the central nervous system, possibly due to an additive effect.</p><p><em>Elderly</em></p><p>The elderly have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which may be fatal (see section 4.2).</p><p><em>Paediatric population</em></p><p>There is a risk of renal impairment in dehydrated children and adolescents.</p><p><em>Gastrointestinal bleeding, ulceration and perforation</em></p><p>GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below and section 4.5).</p><p>Patients with a history of gastrointestinal disease, particularly when elderly, should report any unusual abdominal symptoms (especially gastrointestinal bleeding) particularly in the initial stages of treatment.</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors or anti-platelet agents such as aspirin (see section 4.5).</p><p>When GI bleeding or ulceration occurs in patients receiving Emifen, the treatment should be withdrawn.</p><p>NSAIDs should be given with care to patients with a history of ulcerative colitis or Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8).</p><p><em>Respiratory disorders and hypersensitivity reactions</em></p><p>Caution is required if Emifen is administered to patients suffering from, or with a previous history of, bronchial asthma, chronic rhinitis or allergic diseases since NSAIDs have been reported to precipitate bronchospasm, urticaria or angioedema in such patients.</p><p>Cardiac, renal and hepatic impairment</p><p>The administration of an NSAID may cause a dose dependent reduction in prostaglandin formation and precipitate renal failure. The habitual concomitant intake of various similar painkillers further increases this risk. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics and the elderly. For these patients, use the lowest effective dose, for the shortest possible duration and monitor renal function especially in long-term treated patients (see also section 4.3).</p><p>Emifen should be given with care to patients with a history of heart failure or hypertension since oedema has been reported in association with ibuprofen administration.</p><p><em>Cardiovascular and cerebrovascular effects</em></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>Clinical studies suggest that use of ibuprofen, particularly at a high dose (2400 mg/ day) may be associated with a small increased risk of arterial thrombotic events such as myocardial infarction or stroke. Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. &le; 1200mg/day) is associated with an increased risk of arterial thrombotic events.</p><p>Patients with uncontrolled hypertension, congestive heart failure (NYHA II-III), established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with ibuprofen after careful consideration and high doses (2400mg/day) should be avoided. Careful consideration should also be exercised before initiating long-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking), particularly if high doses of ibuprofen (2400mg/day) are required.</p><p><em>Renal effects</em></p><p>Caution should be used when initiating treatment with ibuprofen in patients with considerable dehydration. There is a risk of renal impairment especially in dehydrated children, adolescents and the elderly.</p><p>As with other NSAIDs, long-term administration of ibuprofen has resulted in renal papillary necrosis and other renal pathologic changes. Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. In these patients, administration of an NSAID may cause a dose-dependant reduction in prostaglandin formation and, secondarily, in renal blood flow, which may cause renal failure. Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors and the elderly. Discontinuation of NSAID therapy is usually followed by recovery to the pre-treatment state.</p><p><em>SLE and mixed connective tissue disease</em></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see below and section 4.8).</p><p>&nbsp;</p><p><em>Severe skin reactions</em></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring within the first month of treatment in the majority of cases. Acute generalised exanthematous pustulosis (AGEP) has been reported in relation to ibuprofen-containing products. Emifen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><p>In exceptional cases, varicella can be at the origin of serious cutaneous and soft tissues infectious complications. To date, the contributing role of NSAIDs in the worsening of these infections cannot be ruled out. Thus, it is advisable to avoid use of Ibuprofen in case of varicella.</p><p><em>Haematological effects</em></p><p>Ibuprofen, like other NSAIDs, can interfere with platelet aggregation and prolong bleeding time in normal subjects.</p><p><em>Aseptic meningitis</em></p><p>Aseptic meningitis has been observed on rare occasions in patients on ibuprofen therapy. Although it is probably more likely to occur in patients with systemic lupus erythematosus and related connective tissue diseases, it has been reported in patients who do not have an underlying chronic disease.</p><p><em>Impaired female fertility</em></p><p>The use of ibuprofen may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Emifen should be considered.</p><p><em>Masking of symptoms of underlying infections</em></p><p>Ibuprofen can mask symptoms of infection, which may lead to delayed initiation of appropriate treatment and thereby worsening the outcome of the infection. This has been observed in bacterial community acquired pneumonia and bacterial complications to varicella. When ibuprofen is administered for fever or pain relief in relation to infection, monitoring of infection is advised. In non-hospital settings, the patient should consult a doctor if symptoms persist or worsen.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Care should be taken in patients treated with any of the following drugs as interactions have been reported in some patients.</p><p>Antihypertensives, beta-blockers and diuretics: NSAIDs may reduce the effect of anti-hypertensives, such as ACE inhibitors, angiotensin-II receptor antagonists, beta-blockers and diuretics.</p><p>Diuretics can also increase the risk of nephrotoxicity of NSAIDs.</p><p>Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma cardiac glycoside levels.</p><p>Cholestyramine; The concomitant administration of ibuprofen and cholestyramine may reduce the absorption of ibuprofen in the gastrointestinal tract. However, the clinical significance is unknown.</p><p>Lithium: Decreased elimination of lithium.</p><p>Methotrexate: NSAIDs may inhibit the tubular secretion of methotrexate and reduce clearance of methotrexate.</p><p>Ciclosporin: Increased risk of nephrotoxicity.</p><p>Mifepristone: A decrease in the efficacy of the medicinal product can theoretically occur due to the antiprostaglandin properties of NSAIDs. Limited evidence suggests that coadministration of NSAIDs on the day of prostaglandin administration does not adversely influence the effects of mifepristone or the prostaglandin on cervical ripening or uterine contractility and does not reduce the clinical efficacy of medicinal termination of pregnancy.</p><p>Other analgesics and cyclooxygenase-2 selective inhibitors: Avoid concomitant use of two or more NSAIDs, including Cox-2 inhibitors, as this may increase the risk of adverse effects (see section 4.4).</p><p>Aspirin (Acetylsalicylic acid): As with other products containing NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential of increased adverse effects.</p><p>Experimental data suggest that ibuprofen may competitively inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. Although there are uncertainties regarding extrapolation of these data to the clinical situation, the possibility that regular, long-term use of ibuprofen may reduce the cardioprotective effect of low-dose acetylsalicylic acid cannot be excluded. No clinically relevant effect is considered to be likely for occasional use (see section 5.1).</p><p>Corticosteroids: Increased risk of gastrointestinal ulceration or bleeding with NSAIDs (see section 4.4).</p><p>Anticoagulants: NSAIDs may enhance the effects of anticoagulants, such as warfarin (see section 4.4).</p><p>Quinolone antibiotics: Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.</p><p>Sulfonylureas: NSAIDs may potentiate the effects of sulfonylurea medications. There have been rare reports of hypoglycaemia in patients on sulfonylurea medications receiving ibuprofen.</p><p>Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): Increased risk of gastrointestinal bleeding with NSAIDs (see section 4.4).</p><p>Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</p><p>Zidovudine: Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p><p>Aminoglycosides: NSAIDs may decrease the excretion of aminoglycosides.</p><p>Herbal extracts: Ginkgo biloba may potentiate the risk of bleeding with NSAIDs.</p><p>CYP2C9 Inhibitors: Concomitant administration of ibuprofen with CYP2C9 inhibitors may increase the exposure to ibuprofen (CYP2C9 substrate). In a study with voriconazole and fluconazole (CYP2C9 inhibitors), an increased S(+)-ibuprofen exposure by approximately 80 to 100% has been shown. Reduction of the ibuprofen dose should be considered when potent CYP2C9 inhibitors are administered concomitantly, particularly when high-dose ibuprofen is administered with either voriconazole or fluconazole.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy</em></p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after the use of a prostaglandin synthesis inhibitor in early pregnancy. The risk is believed to increase with dose and duration of therapy. In animals, the administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation losses and embryo/foetal lethality. In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period.</p><p>During the first and second trimester of pregnancy, ibuprofen should not be given unless clearly necessary. If ibuprofen is used by a woman attempting to conceive, or during the first or second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to the following:</p><p>&bull; Cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension)</p><p>&bull; Renal dysfunction, which may progress to renal failure with oligohydramnios.</p><p>At the end of pregnancy, prostaglandin synthesis inhibitors may expose the mother and the neonate to the following:</p><p>&bull; Possible prolongation of bleeding time</p><p>&bull; Inhibition of uterine contractions, which may result in delayed or prolonged labour.</p><p>Consequently, ibuprofen is contraindicated during the third trimester of pregnancy.</p><p><em>Lactation</em></p><p>In the limited studies so far available, NSAIDs can appear in the breast milk in very low concentrations. NSAIDs should, if possible, be avoided when breastfeeding.</p><p>See section 4.4 Special warnings and precautions for use, regarding female fertility</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected, patients should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrointestinal disorders: The most commonly observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the elderly, may occur (see section 4.4). Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn&#39;s disease (see section 4.4) have been reported following ibuprofen administration. Less frequently, gastritis, duodenal ulcer, gastric ulcer and gastrointestinal perforation have been observed.</p><p>Immune system disorders: Hypersensitivity reactions have been reported following treatment with NSAIDs. These may consist of (a) non-specific allergic reaction and anaphylaxis, (b) respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea, or (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angioedema and, very rarely, erythema multiforme, bullous dermatoses (including Stevens- Johnson syndrome and toxic epidermal necrolysis).</p><p>Cardiac disorders and vascular disorders: Oedema, hypertension and cardiac failure have been reported in association with NSAID treatment. Clinical studies suggest that use of ibuprofen, particularly at high dose (2400 mg/day) may be associated with a small increased risk of arterial thrombotic events such as myocardial infarction or stroke (see section 4.4)<em>.</em></p><p>Infections and infestations: Rhinitis and aseptic meningitis (especially in patients with existing autoimmune disorders, such as systemic lupus erythematosus and mixed connective tissue disease) with symptoms of stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4).</p><p>Exacerbation of infection-related inflammations coinciding with the use of NSAIDs has been described. If signs of an infection occur or get worse during use of Ibuprofen the patient is therefore recommended to go to a doctor without delay.</p><p>Skin and subcutaneous tissue disorders: In exceptional cases, severe skin infections and soft-tissue complications may occur during a varicella infection (see also &quot;Infections and infestations&quot;)</p><p>The following adverse reactions possibly related to ibuprofen and displayed by MedDRA frequency convention and system organ classification. Frequency groupings are classified according to the subsequent conventions: very common (&ge;1/10), Common (&ge;1/100 to &lt;1/10), Uncommon (&ge;1/1,000 to &lt;1/100), Rare (&ge;1/10,000 to &lt;1/1,000), Very rare (&lt;1/10,000) and Not known (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Rhinitis</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Meningitis aseptic (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Leukopenia, thrombocytopenia, neutropenia, agranulocytosis, aplastic anaemia , haemolytic anaemia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>Rare</p></td><td style="vertical-align:top"><p>Hypersensitivity</p><p>Anaphylactic reaction</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Insomnia, anxiety</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Depression, confusional state</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Headache, dizziness</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Paraesthesia, somnolence</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Optic neuritis</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Visual impairment</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Toxic optic neuropathy</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Hearing impaired , tinnitus, vertigo</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Asthma, bronchospasm, dyspnoea</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Dyspepsia, diarrhoea, nausea, vomiting, abdominal pain, flatulence, constipation, melaena, haematemesis, gastrointestinal haemorrhage</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Gastritis, duodenal ulcer, gastric ulcer, mouth ulceration, gastrointestinal perforation</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Pancreatitis</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Exacerbation of Colitis and Crohn&acute;s disease</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Hepatitis, jaundice, hepatic function abnormal</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Hepatic failure</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Rash</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Urticaria, pruritus, purpura, angioedema, photosensitivity reaction</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Severe forms of skin reactions ( e.g. Erythema multiforme, bullous reactions, including Stevens-Johnson syndrome,and toxic epidermal necrolysis)</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)</p><p>Acute generalised exanthematous pustulosis (AGEP)</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Nephrotoxity in various forms e.g.Tubulointerstitial nephritis, nephrotic syndrome and renal failure</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Fatigue</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Oedema</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Cardiac failure, myocardial infarction (also see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hypertension</p></td></tr></tbody></table><p><em>&nbsp;Reporting of suspected adverse reactions</em></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at:</p><p>The National Pharmacovigilance Centre (NPC):</p><p>Fax: +966-11-205-7662,</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</p><p>Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Toxicity</em></p><p>Signs and symptoms of toxicity have generally not been observed at doses below 100 mg/kg in children or adults. However, supportive care may be needed in some cases. Children have been observed to manifest signs and symptoms of toxicity after ingestion of 400 mg/kg or greater.</p><p><em>Symptoms</em></p><p>Most patients who have ingested significant amounts of ibuprofen will manifest symptoms within 4 to 6 hours.</p><p>The most frequently reported symptoms of overdose include nausea, vomiting, abdominal pain, lethargy and drowsiness. Central nervous system (CNS) effects include headache, tinnitus, dizziness, convulsion, and loss of consciousness. Nystagmus, metabolic acidosis, hypothermia, renal effects, gastrointestinal bleeding, coma, apnoea, diarrhoea and depression of the CNS and respiratory system have also been rarely reported. In serious poisoning metabolic acidosis may occur. Disorientation, excitation, fainting and cardiovascular toxicity, including hypotension, bradycardia and tachycardia have been reported. In cases of significant overdose, renal failure and liver damage are possible. Large overdoses are generally well tolerated when no other drugs are being taken.</p><p><em>Therapeutic measures</em></p><p>Patients should be treated symptomatically as required. Within one hour of ingestion of a potentially toxic amount, activated charcoal should be considered. Alternatively, in adults, gastric lavage should be considered within one hour of ingestion of a potentially life-threatening overdose.</p><p>Good urine output should be ensured.</p><p>Renal and liver function should be closely monitored.</p><p>Patients should be observed for at least four hours after ingestion of potentially toxic amounts.</p><p>Frequent or prolonged convulsions should be treated with intravenous diazepam. Other measures may be indicated by the patient&#39;s clinical condition</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic classification: Anti-inflammatory and antirheumatic products, nonsteroidal; propionic acid derivatives.</p><p>ATC code: M01AE01</p><p>Ibuprofen is a propionic acid derivative with analgesic, anti-inflammatory and anti-pyretic activity. The drug&#39;s therapeutic effects as an NSAID is thought to result from its inhibitory effect on the enzyme cyclo-oxygenase, which results in a marked reduction in prostaglandin synthesis.</p><p>Experimental data suggest that ibuprofen may competitively inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. Some pharmacodynamic studies show that when single doses of ibuprofen 400mg were taken within 8 hours before or within 30 minutes after immediate release aspirin dosing (81mg), a decreased effect of aspirin on the formation of thromboxane or platelet aggregation occurred. Although there are uncertainties regarding extrapolation of these data to the clinical situation, the possibility that regular, long-term use of ibuprofen may reduce the cardioprotective effect of low-dose acetylsalicylic acid cannot be excluded. No clinically relevant effect is considered to be likely for occasional ibuprofen use. (see section 4.5)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ibuprofen is rapidly absorbed from the gastrointestinal tract, peak serum concentrations occurring 1-2 hours after administration. The elimination half-life is approximately 2 hours.</p><p>Ibuprofen is metabolised in the liver to two inactive metabolites and these, together with unchanged ibuprofen, are excreted by the kidney either as such or as conjugates. Excretion by the kidney is both rapid and complete.</p><p>Ibuprofen is extensively bound to plasma proteins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maize Starch,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal anhydrous silica ,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purified Talc,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium Lauryl sulfate ,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stearic acid,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pregelatinised Starch,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Opadry white</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Isopropyl Alcohol*</p><p>* Not present in the final formulation, evaporates upon drying</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Don&rsquo;t store above 30&deg;C. Store in a dry place. Protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminum/PVC-PVDC white opaque Blisters of 10 tablets</p><p>Pack size of 20 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Globalpharma Co. L.L.C., Dubai Investment Park, Lahbab Street, Jebel Ali, P.O. Box 72168, Dubai, UAE
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12th November 2020 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>